FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/04/032611 [Registered on: 07/04/2021] Trial Registered Prospectively
Last Modified On: 07/04/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Oropharyngeal leak pressure of LMA Protector Vs LMA Proseal in different head and neck positions 
Scientific Title of Study   Comparison of oropharyngeal leak pressure of LMA Protector with ProSeal LMA in different head and neck positions 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SUKHYANTI KERAI 
Designation  Associate Professor 
Affiliation  Maulana Azad Medical College 
Address  Department of Anaesthesiology & Intensive Care Room no-413 BL Taneja block Maulana Azad Medical College
Bahadur Shah Zafar Marg, New Delhi-110002
Central
DELHI
1100002
India 
Phone  09968527122  
Fax    
Email  drsukhi25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  SUKHYANTI KERAI 
Designation  Associate Professor 
Affiliation  Maulana Azad Medical College 
Address  Department of Anaesthesiology and Intensive Care 413 BL Taneja Block Maulana Azad Medical College
Bahadur Shah Zafar Marg, New Delhi-110002
Central
DELHI
1100002
India 
Phone  09968527122  
Fax    
Email  drsukhi25@gmail.com  
 
Details of Contact Person
Public Query
 
Name  SUKHYANTI KERAI 
Designation  Associate Professor 
Affiliation  Maulana Azad Medical College 
Address  Department of Anaesthesiology and Intensive Care 413 BL Taneja Block Maulana Azad Medical College
Bahadur Shah Zafar Marg, New Delhi-110002
Central
DELHI
1100002
India 
Phone  09968527122  
Fax    
Email  drsukhi25@gmail.com  
 
Source of Monetary or Material Support  
Lok Nayak Hospital, New Delhi 
 
Primary Sponsor  
Name  Maulana Azad Medical College and associated Lok Nayak Hospital 
Address  Bhadur Shah Zafar Marg, New Delhi-110002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sukhyanti Kerai  Lok Nayak Hospital and associated trauma centre  Operation theater block( first, second and third floor)Operation theater in gynaecology building Operation theatres in trauma centre (first floor) Department of Anaesthesilolgy
Central
DELHI 
9968527122

drsukhi25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee MAMC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  LMA Proseal  oropharyngeal seal pressure of LMA Proseal in neutral head position to extended and flexed head positions 
Intervention  LMA Protector  oropharyngeal seal pressure of LMA Protector in neutral head position to extended and flexed head positions will be measured 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Age>18 years
ASA physical status I & II
Anticipated duration of surgery≤ 2 hours
 
 
ExclusionCriteria 
Details  Known or predicted difficult airway
-Patients with pre-existing cervical spine pathology (neck pain or tenderness in cervical spines or associated paraesthesia in upper limbs)
-BMI > 35kg/m2
-Thorax, major upper abdomen, Head & neck surgeries
-Surgeries requiring lateral or prone positioning
-Patient at risk of aspiration such as pregnant patients, those with inadequate fasting, hiatal hernia, gastric outlet obstruction
-Mouth opening less than 3 centimetres

 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
oropharyngeal leak pressures of LMA protector and PLMA in different head and neck positions  after insertion of devices 
 
Secondary Outcome  
Outcome  TimePoints 
number of attempts for successful insertion of devices  after insertion of devices 
time taken for successful insertion of devices  during insertion of devices 
ease of placement of devices  after placement of devices 
ease of placement of nasogastric tubes through devices  after placement of devices 
presence of blood on the cuff of devices  when the device is taken out from patients during extubation 
postoperative sore throat  1, 2 and 24 hours after surgery 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/04/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [drsukhi25@gmail.com].

  6. For how long will this data be available start date provided 01-07-2021 and end date provided 01-12-2023?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   The oropharyngeal leak pressure is marker of efficacy of supraglottic devices. As the pharyngeal anatomy changes accroding to different head and neck position, the performance of supraglottic device may be affected.Proseal LMA is considered criterion standard  supraglottic device and its superiority has been established  in terms of better oropharyngeal leak pressure over LMA Classic, LMA Supreme and i gel.Previous studies have suggested that it can be utilized regardless of head and neck position.
We will be comparing oropharyngeal leak pressures of LMA Protector, a new supraglottic device and LMA Proseal in 70 patients scheduled for elective surgeries. Standrad protocol for preanaesthetic surgery will be followed and consent for participation in trial will be taken.On the day of surgery , general anaesthesia will be induced  in standard manner. Based on computer generated random table patients will be allocated to one of the two groups; in one group LMA protector will be used and in another LMA Proseal . The primary outcome of study will be comparison of oropharyngeal leak pressure of two devices in neutral, flexion, extension and lateral rotation of head and neck. Number of attempts for sucessful insertion, ease of insertion,laryngeal view on fibreoptic bronchoscopy, ease of insertion of nasogastric tube,, presence of blood on cuff of device after extubation and postoperative sore throat.
 
Close